Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis.
D001416:Back Pain / Q000188:drug therapy / Q000517:prevention & control; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D050723:Fractures, Bone / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography; D016103:Spinal Fractures / Q000517:prevention & control; D019379:Teriparatide / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D019379:Teriparatide